The date for the next meeting is Thursday 30th April at 7.00pm Our drop-in Zoom chats provide a good opportunity for the newly diagnosed to meet seasoned travellers and discuss all things KC. Anyone interested in keratoconus is free to join us. To take part, simply send an e-mail to david@keratoconus-group.org.uk to request a link.
Keratoconus is often described as an invisible condition. From the outside, our eyes can look perfectly healthy, while the way we see the world is anything but. Explaining that experience to others can be incredibly difficult — how do you describe ghosting, halos, or smeared lights in a way that truly makes sense? That’s why…
Keratoconus is a progressive eye condition that can make everyday classroom tasks more challenging. With the right adjustments, students can continue to learn confidently and participate fully in school life. This guide outlines practical strategies that schools, colleges and teachers can use to create an inclusive learning environment for children and young people with Keratoconus.…
Epioxa Provides the Ophthalmic Community and Patients with the First and Only FDA-Approved, IncisionFree, Topical Drug Therapy for Keratoconus Epioxa Represents a Novel, Groundbreaking Therapy for Patients Afflicted by This Sight-Threatening Rare Disease Epioxa Expected to Be Commercially Available in Q1 2026 Aliso Viejo, CA – October 20, 2025 – Glaukos Corporation (NYSE: GKOS), an…
By Dr Sangeetha Rao Author’s note:Dr Sangeetha Rao, an Ophthalmologist and new member of the Keratoconus Self-Help and Support Group, shares her reflections from the 2025 Specialist Keratoconus & Scleral Lens Symposium in Hertford, a weekend of learning, collaboration, and connection. As a new member of the Keratoconus Self-Help and Support Group, attending the Specialist…
University of Liverpool researchers receive £2.4 million to advance a minimally invasive treatment for keratoconus, aiming to improve patient access and reduce NHS costs Researchers at the University of Liverpool have secured over £2.4 million in funding to develop a novel, non-invasive treatment for keratoconus, a progressive eye condition that causes the cornea to become…
The National Institute for Health and Care Research (NIHR) have awarded Dr. Shafi Balal a prestigious Doctoral Fellowship at University College London (UCL). The NIHR Doctoral Fellowship is a full-time award that supports individuals to undertake a PhD in an area of research within the NIHR’s remit. The funding will support Dr. Balal in groundbreaking research on using…
Keratoconus (KC) doesn’t just affect your vision – it can also impact your daily life and emotional well-being. Distorted eyesight from KC can interfere with tasks like reading, driving, or recognizing faces, often leading to frustration or anxiety. That’s why coping with keratoconus is about more than just treating the eyes; it’s about preserving your…
ABDO have made us “Charity of the Month”. You can read their article here
Investigator Initiated, Prospective Study of Xenia Corneal Lenticule This information is provided directly by researchers and we recognise that it isn’t always easy to understand. We are working with researchers to improve the accessibility of this information. Cornea ectatic conditions such as keratoconus and post-LASIK (Laser In situ Keratomileusis) ectasia are disorders of the eye…